Authors: Cannons, JL Lau, P Ghumman, B DeBenedette, MA Yagita, H Okumura, K Watts, TH

Citation: Jl. Cannons et al., 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy, J IMMUNOL, 167(3), 2001, pp. 1313-1324

Authors: Guinn, BA Bertram, EM DeBenedette, MA Berinstein, NL Watts, TH

Citation: Ba. Guinn et al., 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors, CELL IMMUN, 210(1), 2001, pp. 56-65

Authors: Watts, TH DeBenedette, MA

Citation: Th. Watts et Ma. Debenedette, T cell co-stimulatory molecules other than CD28, CURR OP IM, 11(3), 1999, pp. 286-293

Authors: DeBenedette, MA Wen, T Bachmann, MF Ohashi, PS Barber, BH Stocking, KL Peschon, JJ Watts, TH

Citation: Ma. Debenedette et al., Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus, J IMMUNOL, 163(9), 1999, pp. 4833-4841

Authors: Guinn, B DeBenedette, MA Watts, TH Berinstein, NL

Citation: B. Guinn et al., 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine, J IMMUNOL, 162(8), 1999, pp. 5003-5010